Unaudited Condensed Interim Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Net Sales	$ 10,843,686	$ 5,907,646	$ 21,498,169	$ 9,263,736
Cost of Goods Sold	8,433,992	4,603,854	17,166,089	6,810,845
Gross Profit	2,409,694	1,303,792	4,332,080	2,452,891
Operating Expenses
Research and development	180,293	82,049	369,503	141,363
Selling General and Administrative Expenses	4,922,119	4,031,215	10,186,498	7,132,441
Loss on impairment of goodwill and intangibles	0	0	0	1,138,203
Total Operating Expenses	5,102,412	4,113,264	10,556,001	8,412,007
Operating Loss	(2,692,718)	(2,809,472)	(6,223,921)	(5,959,116)
Other Income (Expense)
Change in Fair Market Value of Warrant Liability	(1,384)	(32,111)	918	11,717
Interest expense	(483,122)	(49,020)	(876,061)	(53,076)
Gain (Loss) on change in Fair Market Value of Contingent Consideration	186,000	0	(433,999)	(240,000)
Gain on Settlement of Contingent Consideration (Note 2)	0	0	0	1,700,000
Other Income	0	1,948	0	1,948
Total Other Income (Expense)	(298,506)	(79,183)	(1,309,142)	1,420,589
Loss Before Provision for Income Taxes	(2,991,224)	(2,888,655)	(7,533,063)	(4,538,527)
Benefit from Income Taxes	0	0	0	0
Net Loss	(2,991,224)	(2,888,655)	(7,533,063)	(4,538,527)
Net Loss attributable to common stockholders:
Dividends to preferred shareholders	(407,231)	(362,250)	(769,481)	(724,500)
Net Loss attributable to common stockholders	$ (3,398,455)	$ (3,250,905)	$ (8,302,544)	$ (5,263,027)